| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |